Radiopharm Theranostics Limited (RAD.AX)
AUD 0.02
(-8.7%)
AUD 0.02
(-8.7%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -18.57 Million AUD | -58.77% |
| 2023 | -11.69 Million AUD | 56.64% |
| 2022 | -26.97 Million AUD | -84650.14% |
| 2021 | 31.9 Thousand AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -1.89 Million AUD | 92.98% |
| 2024 Q2 | -1.89 Million AUD | 0.0% |
| 2024 Q3 | -18.57 Million AUD | -880.77% |
| 2024 Q4 | -18.57 Million AUD | 0.0% |
| 2024 FY | -18.57 Million AUD | -58.77% |
| 2023 Q4 | -26.97 Million AUD | -130.61% |
| 2023 FY | -11.69 Million AUD | 56.64% |
| 2023 Q3 | -11.69 Million AUD | 51.75% |
| 2023 Q2 | -24.24 Million AUD | 0.0% |
| 2023 Q1 | -24.24 Million AUD | 10.13% |
| 2022 Q4 | -26.97 Million AUD | 0.0% |
| 2022 Q3 | -26.97 Million AUD | 17.22% |
| 2022 Q2 | -32.58 Million AUD | 0.0% |
| 2022 Q1 | -32.58 Million AUD | 0.0% |
| 2022 FY | -26.97 Million AUD | -84650.14% |
| 2021 FY | 31.9 Thousand AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | -18.89 Million AUD | 1.713% |
| Anatara Lifesciences Ltd | -982.1 Thousand AUD | -1791.346% |
| Zelira Therapeutics Limited | 5.06 Million AUD | 466.565% |
| Biome Australia Limited | -1.56 Million AUD | -1088.569% |
| Patrys Limited | -2.24 Million AUD | -728.998% |
| Orthocell Limited | -19.92 Million AUD | 6.774% |
| Imugene Limited | -91.56 Million AUD | 79.713% |
| Noxopharm Limited | -2.31 Million AUD | -700.673% |
| PYC Therapeutics Limited | -65.76 Million AUD | 71.754% |
| Chimeric Therapeutics Limited | -3.05 Million AUD | -508.419% |
| Prescient Therapeutics Limited | -10.16 Million AUD | -82.777% |
| Proteomics International Laboratories Limited | -6.32 Million AUD | -193.73% |
| Cynata Therapeutics Limited | -6.2 Million AUD | -199.336% |
| CSL Limited | 15.76 Billion AUD | 100.118% |
| Arovella Therapeutics Limited | -12.71 Million AUD | -46.094% |
| Bio-Gene Technology Limited | -709.55 Thousand AUD | -2517.833% |
| Clinuvel Pharmaceuticals Limited | -182.98 Million AUD | 89.849% |
| Starpharma Holdings Limited | -19.83 Million AUD | 6.338% |
| Nanollose Limited | -96.22 Thousand AUD | -19203.757% |
| Memphasys Limited | 4.13 Million AUD | 549.175% |
| Invex Therapeutics Ltd | -6.02 Million AUD | -208.296% |
| NeuroScientific Biopharmaceuticals Limited | -4.95 Million AUD | -274.94% |
| Amplia Therapeutics Limited | -1.82 Million AUD | -918.597% |
| Botanix Pharmaceuticals Limited | -79.3 Million AUD | 76.579% |
| Island Pharmaceuticals Limited | -1.23 Million AUD | -1399.912% |
| Race Oncology Limited | -17.18 Million AUD | -8.065% |
| Nyrada Inc. | -4.76 Million AUD | -289.465% |
| Telix Pharmaceuticals Limited | -105.79 Million AUD | 82.442% |
| Dimerix Limited | -21.99 Million AUD | 15.536% |
| PharmAust Limited | -9.71 Million AUD | -91.217% |
| Immutep Limited | -122.18 Million AUD | 84.798% |
| Clarity Pharmaceuticals Ltd | -136.5 Million AUD | 86.392% |
| Alterity Therapeutics Limited | -12.47 Million AUD | -48.84% |
| BTC Health Limited | -2.02 Million AUD | -818.576% |
| Acrux Limited | -1.45 Million AUD | -1174.008% |
| Neuren Pharmaceuticals Limited | -17.09 Million AUD | -8.664% |
| Biotron Limited | -386.06 Thousand AUD | -4711.339% |
| Tissue Repair Ltd | -16.44 Million AUD | -12.98% |
| AdAlta Limited | -845.17 Thousand AUD | -2097.78% |
| Hexima Limited | -2.22 Million AUD | -734.378% |
| AnteoTech Limited | -5 Million AUD | -271.388% |
| Paradigm Biopharmaceuticals Limited | -17.58 Million AUD | -5.651% |
| Recce Pharmaceuticals Ltd | -3.39 Million AUD | -446.947% |
| Avecho Biotechnology Limited | -5.32 Million AUD | -248.549% |
| Actinogen Medical Limited | -9.13 Million AUD | -103.413% |
| Immuron Limited | -11.48 Million AUD | -61.75% |
| Argenica Therapeutics Limited | -15.91 Million AUD | -16.731% |